Compare SDGR & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SDGR | PRGO |
|---|---|---|
| Founded | 1990 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2020 | 2013 |
| Metric | SDGR | PRGO |
|---|---|---|
| Price | $23.88 | $16.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $25.57 | $16.50 |
| AVG Volume (30 Days) | 2.3M | ★ 2.7M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 7.09% |
| EPS Growth | ★ 45.14 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $255,869,000.00 | $800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.09 | $0.74 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 23.29 | N/A |
| 52 Week Low | $10.95 | $9.23 |
| 52 Week High | $33.78 | $22.01 |
| Indicator | SDGR | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 44.96 | 60.32 |
| Support Level | $11.27 | $13.55 |
| Resistance Level | $31.59 | N/A |
| Average True Range (ATR) | 1.93 | 0.66 |
| MACD | -0.71 | 0.05 |
| Stochastic Oscillator | 17.76 | 75.87 |
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.